TABLE 1.
Mutant | Relative infection avga | No. of infections |
---|---|---|
DQ 2 | 1 (NA)c | 5 |
R 23 D | 0.59 ± 0.11 | 4 |
R 25 D | 0.71 ± 0.16 | 3 |
R 34 E | 0.94 ± 0.23 | 3 |
E 36 K | 0b | 3 |
D 41 A | 0.79 ± 0.03 | 4 |
D 43 A | 0.53 ± 0.05 | 4 |
R 48 E | 0.72 ± 0.27 | 5 |
E 69 K | 0.57 ± 0.21 | 4 |
S 42 A | 1.1 ± 0.20 | 4 |
S 42 K | 0.8 ± 0.09 | 4 |
E 46 K | 0.08 ± 0.06 | 3 |
S 63 A | 0.72 ± 0.20 | 4 |
S 63 K | 0.57 ± 0.37 | 3 |
K 65 A | 1.09 ± 0.16 | 3 |
K 65 E | 0.12 ± 0.10 | 4 |
R 72 A | 0.26 ± 0.10 | 4 |
R 72 E | 0.00 ± 0.01 | 4 |
This number is equal to the relative infection rate with the standard deviation for each mutant. For each experiment, the percentage of GFP-positive cells was divided by the percentage of HLA-DQ-positive cells in and compared to the ratio for wild-type DQ 2 when it was set at 1.
No surface expression was detected.
NA, not applicable.